Six years ago Abiraterone was hailed as a medical breakthrough that could offer men extra time with loved ones and a chance to delay chemotherapy and its debilitating side effects.
Today the body that recommends what can and cannot be paid for said it 'wasn't cost effective'.
Prostate cancer patients have now been told that the life-extending drug will not be routinely prescribed unless they have chemotherapy.
One man from North Yorkshire who is fighting prostate cancer is calling for a rethink:
More top news
Sunday should be a brighter day than Saturday across the region, especially further south. Still breezy though
Not too bad through Yorkshire and Lincolnshire on Saturday, generally bright, patchy cloud, odd light shower possible anywhere. Breezy
Clear skies but a chilly night ahead